The Ki‐67 and TUNEL staining validated that sorafenib suppressed the proliferation of HCC cells and induced apoptosis in vitro, with these effects further enhanced by cotreatment (Figure 6h). The gene discussed is MKI67; the disease is hepatocellular carcinoma.